Hepatic epithelioid hemangioendothelioma in a patient with hemochromatosis

Nisar Ahmad, Denise M. Adams, Jiang Wang, Rajan Prakash, Nagla Abdel Karim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hepatic epithelioid hemangioendothelioma (HEHE) is a rare hepatic vascular tumor that represents a diagnostic challenge. The rarity of this neoplasm precludes establishment of a standard-ofcare treatment. Risk factors for HEHE are not well-known. Liver transplant remains the most common therapeutic modality for nonmetastatic disease. This article describes a patient who presented with abdominal pain, fatigue, poor appetite, and weight loss. Genetic testing showed that the patient was homozygous for C282Y consistent with hereditary hemochromatosis, and liver biopsy was consistent with malignant epithelioid hemangioendothelioma. The patient was referred for a liver transplant but was deemed inappropriate for transplant secondary to peritoneal studding, with frozen-section analysis showing metastatic disease at the time of surgery.

Original languageEnglish (US)
Pages (from-to)1203-1207
Number of pages5
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume12
Issue number9
DOIs
StatePublished - Sep 1 2014
Externally publishedYes

Fingerprint

Epithelioid Hemangioendothelioma
Hemochromatosis
Liver
Transplants
Frozen Sections
Genetic Testing
Appetite
Abdominal Pain
Fatigue
Blood Vessels
Weight Loss
Neoplasms
Biopsy
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Hepatic epithelioid hemangioendothelioma in a patient with hemochromatosis. / Ahmad, Nisar; Adams, Denise M.; Wang, Jiang; Prakash, Rajan; Karim, Nagla Abdel.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 12, No. 9, 01.09.2014, p. 1203-1207.

Research output: Contribution to journalArticle

Ahmad, Nisar ; Adams, Denise M. ; Wang, Jiang ; Prakash, Rajan ; Karim, Nagla Abdel. / Hepatic epithelioid hemangioendothelioma in a patient with hemochromatosis. In: JNCCN Journal of the National Comprehensive Cancer Network. 2014 ; Vol. 12, No. 9. pp. 1203-1207.
@article{aff74d8978bd448d850c2bbefa01db0b,
title = "Hepatic epithelioid hemangioendothelioma in a patient with hemochromatosis",
abstract = "Hepatic epithelioid hemangioendothelioma (HEHE) is a rare hepatic vascular tumor that represents a diagnostic challenge. The rarity of this neoplasm precludes establishment of a standard-ofcare treatment. Risk factors for HEHE are not well-known. Liver transplant remains the most common therapeutic modality for nonmetastatic disease. This article describes a patient who presented with abdominal pain, fatigue, poor appetite, and weight loss. Genetic testing showed that the patient was homozygous for C282Y consistent with hereditary hemochromatosis, and liver biopsy was consistent with malignant epithelioid hemangioendothelioma. The patient was referred for a liver transplant but was deemed inappropriate for transplant secondary to peritoneal studding, with frozen-section analysis showing metastatic disease at the time of surgery.",
author = "Nisar Ahmad and Adams, {Denise M.} and Jiang Wang and Rajan Prakash and Karim, {Nagla Abdel}",
year = "2014",
month = "9",
day = "1",
doi = "10.6004/jnccn.2014.0119",
language = "English (US)",
volume = "12",
pages = "1203--1207",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "9",

}

TY - JOUR

T1 - Hepatic epithelioid hemangioendothelioma in a patient with hemochromatosis

AU - Ahmad, Nisar

AU - Adams, Denise M.

AU - Wang, Jiang

AU - Prakash, Rajan

AU - Karim, Nagla Abdel

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Hepatic epithelioid hemangioendothelioma (HEHE) is a rare hepatic vascular tumor that represents a diagnostic challenge. The rarity of this neoplasm precludes establishment of a standard-ofcare treatment. Risk factors for HEHE are not well-known. Liver transplant remains the most common therapeutic modality for nonmetastatic disease. This article describes a patient who presented with abdominal pain, fatigue, poor appetite, and weight loss. Genetic testing showed that the patient was homozygous for C282Y consistent with hereditary hemochromatosis, and liver biopsy was consistent with malignant epithelioid hemangioendothelioma. The patient was referred for a liver transplant but was deemed inappropriate for transplant secondary to peritoneal studding, with frozen-section analysis showing metastatic disease at the time of surgery.

AB - Hepatic epithelioid hemangioendothelioma (HEHE) is a rare hepatic vascular tumor that represents a diagnostic challenge. The rarity of this neoplasm precludes establishment of a standard-ofcare treatment. Risk factors for HEHE are not well-known. Liver transplant remains the most common therapeutic modality for nonmetastatic disease. This article describes a patient who presented with abdominal pain, fatigue, poor appetite, and weight loss. Genetic testing showed that the patient was homozygous for C282Y consistent with hereditary hemochromatosis, and liver biopsy was consistent with malignant epithelioid hemangioendothelioma. The patient was referred for a liver transplant but was deemed inappropriate for transplant secondary to peritoneal studding, with frozen-section analysis showing metastatic disease at the time of surgery.

UR - http://www.scopus.com/inward/record.url?scp=84907296918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907296918&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2014.0119

DO - 10.6004/jnccn.2014.0119

M3 - Article

C2 - 25190690

AN - SCOPUS:84907296918

VL - 12

SP - 1203

EP - 1207

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 9

ER -